market access strategy

Healthcare commercialization strategies in 2026 are defined less by product launch mechanics and more by regulatory alignment, reimbursement architecture, and capital efficiency. In the United States, success increasingly depends on synchronizing clinical development with FDA engagement, CMS coverage planning, and investor expectations well before pivotal data readouts. Biotechnology and medical technology companies now treat commercialization … Read more